LIQUI SRS Trademark

Trademark Overview


On Monday, November 6, 2023, a trademark application was filed for LIQUI SRS with the United States Patent and Trademark Office. The USPTO has given the LIQUI SRS trademark a serial number of 98256227. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, January 23, 2026. This trademark is owned by EMOVIAR PharmaCon GmbH. The LIQUI SRS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; pharmaceutical formulation in the nature of pharmaceutical products development; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations in particular sustained release formulations and medicines; pharmaceutical research services.
liqui srs

General Information


Serial Number98256227
Word MarkLIQUI SRS
Filing DateMonday, November 6, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, January 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2025

Trademark Statements


Goods and ServicesDrug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; pharmaceutical formulation in the nature of pharmaceutical products development; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations in particular sustained release formulations and medicines; pharmaceutical research services.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 30, 2023
Primary Code042
First Use Anywhere DateThursday, October 26, 2023
First Use In Commerce DateThursday, October 26, 2023

Trademark Owner History


Party NameEMOVIAR PharmaCon GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressD-79664 Wehr 79664
DE

Party NameEMOVIAR PharmaCon GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressD-79664 Wehr 79664
DE

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023NEW APPLICATION ENTERED
Thursday, November 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2024ASSIGNED TO EXAMINER
Wednesday, June 26, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 26, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 8, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 7, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 7, 2025TEAS STATEMENT OF USE RECEIVED
Friday, January 9, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 7, 2025USE AMENDMENT FILED
Tuesday, January 13, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, January 23, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 23, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED